ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,950.96
      0.33%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Stevanato Group SpA (STVN)

      7. Stevanato Group SpA (STVN) News

      STVN

      Stevanato (STVN)

      Stevanato Group SpA
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:STVN
      DateTimeSourceHeadlineSymbolCompany
      05/31/20244:30PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:STVNStevanato Group SpA
      05/30/20245:00AMBusiness WireStevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and CartridgesNYSE:STVNStevanato Group SpA
      05/28/20244:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      05/28/20247:00AMBusiness WireStevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco MoroNYSE:STVNStevanato Group SpA
      05/24/20244:51PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      05/24/20244:10PMBusiness WireStevanato Group Announces Results of Annual General MeetingNYSE:STVNStevanato Group SpA
      05/23/20244:30PMBusiness WireStevanato Group to Present at Upcoming Investor ConferencesNYSE:STVNStevanato Group SpA
      05/20/20244:37PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:STVNStevanato Group SpA
      05/16/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      05/14/20244:40PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      05/09/20244:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      05/09/20246:39AMBusiness WireStevanato Group Reports Financial Results for the First Quarter of 2024NYSE:STVNStevanato Group SpA
      05/01/20244:30PMBusiness WireStevanato Group to Present at the Bank of America Securities Healthcare ConferenceNYSE:STVNStevanato Group SpA
      04/25/20244:04PMBusiness WireStevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024NYSE:STVNStevanato Group SpA
      04/04/20248:00AMBusiness WireStevanato Group appoints Ugo Gay as Chief Operations OfficerNYSE:STVNStevanato Group SpA
      03/26/20244:10PMBusiness WireStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary SharesNYSE:STVNStevanato Group SpA
      03/21/202411:45PMBusiness WireStevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
      03/20/20245:12PMBusiness WireStevanato Group Announces Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
      03/11/20245:05PMBusiness WireStevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumNYSE:STVNStevanato Group SpA
      03/07/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      03/07/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      03/07/20246:30AMBusiness WireStevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023NYSE:STVNStevanato Group SpA
      02/22/20244:30PMBusiness WireStevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024NYSE:STVNStevanato Group SpA
      01/24/20248:00AMBusiness WireStevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and CommercializationNYSE:STVNStevanato Group SpA
      01/03/20244:30PMBusiness WireStevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:STVNStevanato Group SpA
      11/16/20236:00AMBusiness WireStevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma ManufacturingNYSE:STVNStevanato Group SpA
      11/09/20234:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      11/09/20236:30AMBusiness WireStevanato Group to Present at the Jefferies London Healthcare ConferenceNYSE:STVNStevanato Group SpA
      11/03/20234:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
      10/31/202311:58AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
       Showing the most relevant articles for your search:NYSE:STVN